Menu Philippe Insider Trades

Insider Trading History

Track insider trading activity for Menu Philippe. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.2M 250,780 shares
Last Trade
May 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$24.8k 5,000 shares
$4.95
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.22M 255,780 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.8k 608 shares
$4.61
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.23M 256,388 shares
Last Trade
May 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.4k 5,000 shares
$4.67
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.25M 261,388 shares
Last Trade
Apr 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$24.1k 5,000 shares
$4.82
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.27M 266,388 shares
Last Trade
Apr 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.16k 608 shares
$5.20
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.28M 266,996 shares
Last Trade
Apr 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.94k 1,600 shares
$4.96
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.3M 271,996 shares
Last Trade
Apr 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.9k 4,400 shares
$4.76
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.3M 272,996 shares
Last Trade
Apr 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.4k 3,725 shares
$4.68
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.32M 276,721 shares
Last Trade
Apr 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.15k 1,931 shares
$4.74
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.33M 278,652 shares
Last Trade
Apr 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.6k 2,800 shares
$4.84
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.35M 281,452 shares
Last Trade
Apr 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7k 2,400 shares
$4.87
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.36M 283,852 shares
Last Trade
Apr 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.1k 2,700 shares
$4.85
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $787k 164,671 shares
Last Trade
Apr 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 277,607 shares
$5.04
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $1.37M 286,552 shares
Last Trade
Apr 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$569k 112,936 shares
$5.04
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $830k 173,616 shares
Last Trade
Mar 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.82k 1,216 shares
$4.79
$4.78
SOPHiA Genetics SA
SOPHiA Genetics SA SOPH
Chief Medical Officer
Holding Value $833k 174,224 shares
Last Trade
Mar 18, 2026 Sale
$4.75M 968,244 shares
$4.91
$4.78

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up